SuperworthAcurx Pharmaceuticals market cap ACXP
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $6M
- Highest close in our data
- $70M
- Oct 2023
Acurx Pharmaceuticals is worth $6M at the close on Oct 23, 2026, at $1.14 a share.
That is down 42% over the last year and down 88% over five years.
Its highest close in our data was $70M in Oct 2023.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $6M | $2.8M | $16M | −10% |
| 2025 | $6.7M | $5.2M | $15M | −56% |
| 2024 | $15.1M | $12.7M | $63.7M | −71% |
| 2023 | $52.7M | $19.5M | $70M | +14% |
| 2022 | $46.1M | $26.2M | $49.8M | +5% |
| 2021 | $44.1M | $41.4M | $58.5M | n/a |
Against its peers
Companies in Healthcare nearest Acurx Pharmaceuticals' size, closest first, today.
| Company | Market cap |
|---|---|
| ACXPAcurx Pharmaceuticals | $6M |
| NEPHNephros | $38.3M |
| ATNMActinium Pharmaceuticals | $47.8M |
| APTAlpha Pro Tech | $56.7M |
| Peer median | $47.8M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Acurx Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.